Histological remission during corticosteroid therapy of overlapping nonalcoholic steatohepatitis and autoimmune hepatitis: Case report and literature review

Case Reports in Gastroenterology

Volumn 5, Issue 3, 2011, Pages 553-557

  Fukuda, Shinichiroh ^a   Komori, Atsumasa ^a,b   Itoh, Masahiro ^a,b   Mihara, Yumi ^a   Hashimoto, Satoru ^a   Bae, Sung Kwan ^a,b   Nagaoka, Shinya ^a   Abiru, Seigo ^a   Yatsuhashi, Hiroshi ^a,b   Ishibashi, Hiromi ^a,b  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Autoimmune hepatitis; Corticosteroid therapy; Histological remission; Nonalcoholic steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; CORTICOSTEROID; PREDNISOLONE; URSODEOXYCHOLIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE COURSE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; REMISSION; WEIGHT REDUCTION;

EID: 84855256732     PISSN: None     EISSN: 16620631     Source Type: Journal    
DOI: 10.1159/000332152     Document Type: Article

References (15)

1. Bedossa P, Moucari R, Chelbi E, Asselah T, Paradis V, Vidaud M, Cazals-Hatem D, Boyer N, Valla D, Marcellin P: Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: A prospective study. Hepatology 2007;46:380-387. (Pubitemid 47344772)
2. Adams LA, Lindor KD, Angulo P: The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2004;99:1316-1320. (Pubitemid 39062269)
3. Yatsuji S, Hashimoto E, Kaneda H, Taniai M, Tokushige K, Shiratori K: Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? J Gastroenterol 2005;40:1130-1138. (Pubitemid 43124840)
4. Matsumoto T, Yamasaki S, Arakawa A, Abe K, Abe H, Kon K, Kobayashi S, Takasaki Y: Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatitis. Pathol Int 2007;57:388-389. (Pubitemid 46849040)
5. Czaja AJ, Manns MP: Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 2010;139:58-72.
6. Loria P, Lonardo A, Leonardi F, Fontana C, Carulli L, Verrone AM, Borsatti A, Bertolotti M, Cassani F, Bagni A, Muratori P, Ganazzi D, Bianchi FB, Carulli N: Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci 2003;48:2173-2181. (Pubitemid 38037305)
7. Ishak K, Baptista A, Bianchi L, et al.: Histological grading and staging of chronic hepatitis. J Hepatol 1995;22: 696-699.
8. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321. (Pubitemid 40770284)
9. Czaja AJ, Carpenter HA: Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 2004;40:646-652. (Pubitemid 38367787)
10. Czaja AJ, Carpenter HA: Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology 2004;39:1631-1638. (Pubitemid 38702664)
11. Malekzadeh R, Mohamadnejad M, Nasseri-Moghaddam S, Rakhshani N, Tavangar SM, Sohrabpour AA, Tahaghoghi S: Reversibility of cirrhosis in autoimmune hepatitis. Am J Med 2004;117:125-129. (Pubitemid 38953734)
12. Herzig S: Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol 2007;275:43-61.
13. Targher G, Bertolini L, Rodella S, Zoppini G, Zenari L, Falezza G: Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. Clin Endocrinol 2006;64:337-341.
14. Nanki T, Koike R, Miyasaka N: Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis. Am J Gastroenterol 1999;94:3379.
15. Lemke U, Krones-Herzig A, Berriel Diaz M, Narvekar P, Ziegler A, Vegiopoulos A, Cato AC, Bohl S, Klingmuller U, Screaton RA, Muller-Decker K, Kersten S, Herzig S: The glucocorticoid receptor controls hepatic dyslipidemia through Hes1. Cell Metab 2008;8:212-223.